Name | Number of supported studies | Average coverage | |
---|---|---|---|
GABAergic neuron | 3 studies | 23% ± 7% | |
glutamatergic neuron | 3 studies | 24% ± 3% | |
interneuron | 3 studies | 36% ± 6% |
Insufficient scRNA-seq data for expression of NECAB2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 86% | 4331.27 | 2267 / 2642 | 96% | 28.72 | 674 / 705 |
liver | 73% | 733.39 | 164 / 226 | 71% | 18.93 | 289 / 406 |
ureter | 0% | 0 | 0 / 0 | 100% | 3.61 | 1 / 1 |
kidney | 48% | 416.78 | 43 / 89 | 49% | 4.53 | 440 / 901 |
eye | 0% | 0 | 0 / 0 | 94% | 36.29 | 75 / 80 |
pancreas | 5% | 15.05 | 16 / 328 | 46% | 4.91 | 81 / 178 |
peripheral blood | 48% | 339.53 | 450 / 929 | 0% | 0 | 0 / 0 |
uterus | 11% | 36.14 | 18 / 170 | 17% | 2.51 | 78 / 459 |
skin | 0% | 0.26 | 1 / 1809 | 27% | 3.12 | 129 / 472 |
adrenal gland | 1% | 2.93 | 2 / 258 | 20% | 2.69 | 47 / 230 |
lung | 1% | 1.09 | 3 / 578 | 20% | 1.92 | 226 / 1155 |
esophagus | 0% | 0.14 | 1 / 1445 | 12% | 1.17 | 22 / 183 |
intestine | 9% | 26.20 | 85 / 966 | 3% | 0.21 | 16 / 527 |
ovary | 1% | 1.08 | 1 / 180 | 10% | 0.76 | 45 / 430 |
breast | 4% | 13.27 | 18 / 459 | 7% | 0.32 | 76 / 1118 |
spleen | 8% | 27.52 | 20 / 241 | 0% | 0 | 0 / 0 |
bladder | 0% | 0 | 0 / 21 | 6% | 0.67 | 30 / 504 |
stomach | 4% | 8.89 | 13 / 359 | 1% | 0.05 | 3 / 286 |
adipose | 3% | 7.77 | 34 / 1204 | 0% | 0 | 0 / 0 |
thymus | 1% | 2.28 | 6 / 653 | 1% | 0.18 | 6 / 605 |
heart | 1% | 2.42 | 8 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 1% | 1.83 | 8 / 1335 | 0% | 0 | 0 / 0 |
prostate | 0% | 0 | 0 / 245 | 0% | 0.03 | 2 / 502 |
muscle | 0% | 0.40 | 1 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 45 |
GO_0060168 | Biological process | positive regulation of adenosine receptor signaling pathway |
GO_1905477 | Biological process | positive regulation of protein localization to membrane |
GO_0070374 | Biological process | positive regulation of ERK1 and ERK2 cascade |
GO_1900451 | Biological process | positive regulation of glutamate receptor signaling pathway |
GO_1904021 | Biological process | negative regulation of G protein-coupled receptor internalization |
GO_0042984 | Biological process | regulation of amyloid precursor protein biosynthetic process |
GO_0030424 | Cellular component | axon |
GO_0005886 | Cellular component | plasma membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0030425 | Cellular component | dendrite |
GO_0031687 | Molecular function | A2A adenosine receptor binding |
GO_0005509 | Molecular function | calcium ion binding |
GO_0005515 | Molecular function | protein binding |
GO_0031802 | Molecular function | type 5 metabotropic glutamate receptor binding |
Gene name | NECAB2 |
Protein name | N-terminal EF-hand calcium-binding protein 2 (EF-hand calcium-binding protein 2) (Neuronal calcium-binding protein 2) (Synaptotagmin-interacting protein 2) (Stip-2) Alternative protein NECAB2 N-terminal EF-hand calcium binding protein 2 |
Synonyms | EFCBP2 |
Description | FUNCTION: May act as a signaling scaffold protein that senses intracellular calcium. Can modulate ligand-induced internalization of ADORA2A and coupling efficiency of mGluR5/GRM5; for both receptors may regulate signaling activity such as promoting MAPK1/3 (ERK1/2) activation. . |
Accessions | ENST00000305202.9 [Q7Z6G3-1] ENST00000566836.1 ENST00000564166.1 Q7Z6G3 H3BPH6 H3BQC7 L8E8I4 ENST00000565691.5 [Q7Z6G3-2] |